Beta Bionics Inc.

NASDAQ: BBNX · Real-Time Price · USD
17.04
0.33 (1.97%)
At close: Aug 15, 2025, 3:59 PM
17.04
0.03%
After-hours: Aug 15, 2025, 05:33 PM EDT

Beta Bionics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-16.87M -28.66M -18.11M -9.74M -14.46M -12.45M -18.85M -8.68M
Depreciation & Amortization
653K 604K 529K n/a 576K 563K 544K n/a
Stock-Based Compensation
4.8M 2.8M 1.55M 1.98M n/a 1.36M 1.58M 1.27M
Other Working Capital
2M -6.69M 2.95M 622K 2.79M -966K 1.91M n/a
Other Non-Cash Items
-678K 11.74M 4.99M -516K 4.34M 3.27M 11.87M 7.41M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.5M -6.47M -3.24M -1.34M -2.69M -4.88M -1.48M n/a
Operating Cash Flow
-13.59M -19.98M -14.28M -9.61M -12.24M -12.14M -6.35M n/a
Capital Expenditures
-1.78M -333K -561K -1.92M -507K -406K -313K n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-15.05M -206.79M -45.1M -6.84M -20.19M n/a n/a n/a
Sales Maturities Of Investments
23M 28M 16M 24M 24M 8M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a 50K -69.3M n/a
Investing Cash Flow
6.17M -179.12M -29.66M 15.24M 3.3M 7.64M -69.61M n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 98K n/a 119K -119K 6K 9K n/a
Financial Cash Flow
42K 211.12M 56.89M -1.18M -107K 6K 9K n/a
Net Cash Flow
-7.38M 12.02M 12.95M 17.48M n/a -4.49M 26.67M n/a
Free Cash Flow
-15.37M -20.31M -14.84M -11.53M -12.74M -12.55M -6.66M n/a